Cargando…
Estimating the re-identification risk of clinical data sets
BACKGROUND: De-identification is a common way to protect patient privacy when disclosing clinical data for secondary purposes, such as research. One type of attack that de-identification protects against is linking the disclosed patient data with public and semi-public registries. Uniqueness is a co...
Autores principales: | Dankar, Fida Kamal, El Emam, Khaled, Neisa, Angelica, Roffey, Tyson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583146/ https://www.ncbi.nlm.nih.gov/pubmed/22776564 http://dx.doi.org/10.1186/1472-6947-12-66 |
Ejemplares similares
-
Evaluating the risk of patient re-identification from adverse drug event reports
por: El Emam, Khaled, et al.
Publicado: (2013) -
A method for managing re-identification risk from small geographic areas in Canada
por: El Emam, Khaled, et al.
Publicado: (2010) -
The re-identification risk of Canadians from longitudinal demographics
por: El Emam, Khaled, et al.
Publicado: (2011) -
De-identifying a public use microdata file from the Canadian national discharge abstract database
por: Emam, Khaled El, et al.
Publicado: (2011) -
The Use of Electronic Data Capture Tools in Clinical Trials: Web-Survey of 259 Canadian Trials
por: El Emam, Khaled, et al.
Publicado: (2009)